Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential ...

Bambusa Therapeutics, Inc. ('Bambusa'), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

“Endotyping-informed therapy in the MRI-guided intervention arm led to a reduction in angina burden and an improvement in health-related quality of life,” reported the principal investigator Colin ...

Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...

Nandita Vijayasimha, Bengaluru Monday, November 17, 2025, 08:00 Hrs [IST] ...

IIM Calcutta, in collaboration with TimesPro, has opened admissions for the fifth cohort of its 12-month Executive Programme ...

Chronic insomnia needs evidence-based care, not pills or products. Consistent habits, CBT-I, and understanding sleep—not chasing metrics—create real, lasting improvement.

The findings of two RCTs suggest estetrol has promise as an additional estrogen formulation option for postmenopausal women.

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

The APAC Precision Oncology Conference 2025, themed Artificial Intelligence (AI) & Multi-omics in Cancer Management, convened in Hong Kong on November 1, marking Lung Cancer Awareness Month with a cle ...